Vasopressin infusion in children with catecholamine-resistant septic shock

Acta Paediatrica, International Journal of Paediatrics

Volumn 94, Issue 3, 2005, Pages 380-383

  Vasudevan, A ^a   Lodha, R ^a   Kabra, S K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Septic shock; Vasopressin

Indexed keywords

ARGIPRESSIN; CATECHOLAMINE; HYPERTENSIVE AGENT; INOTROPIC AGENT;

ADOLESCENT; ARTICLE; CAPILLARY PERMEABILITY; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG INFUSION; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; HYPOTENSION; INFANT; MALE; PRIORITY JOURNAL; SEPTIC SHOCK; TISSUE PERFUSION; TREATMENT OUTCOME;

ADOLESCENT; CATECHOLAMINES; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; SHOCK, SEPTIC; TREATMENT FAILURE; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 16844374499     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035250410022459     Document Type: Article

References (15)

1. Carcillo AJ, Fields AI. Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 2002;30:1365-78.
2. Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997;25:1279-82.
3. Malay MB, Ashton RC Jr, Landry DW, Townsend RN. Low dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999;47:699-703.
4. Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA. Hemodynamic and metabolic effects of low dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001;29:487-93.
5. Rosenzweig EB, Starc TJ, Chen JM, Cullinane S, Timchak DM, Gersony WM, et al. Intravenous arginine - vasopressin in children with vasodilatory shock after cardiac surgery. Circulation 1999;100 Suppl 19II:182-6.
6. Liedel JL, Meadow W, Nachman J, Koogler T, Kahana MD. Use of vasopressin in refractory hypotension in children with vasodilatory shock: Five cases and a review of the literature. Pediatr Crit Care Med 2002;3:15-8.
7. Kasting NW, Mazurek MF, Martin JB. Endotoxin increases vasopressin release independently of known physiologic stimuli. Am J Physiol 1985;248:E420-4.
8. Steckel RJ, Kolin A, MacAlpin RN, Snow HD, Juillard GF, Tesler AS, et al. Differential effects of pitressin on blood flow and oxygen extraction in canine vascular beds. AJR Am J Roentgenol 1978;130:1025-32.
9. Fox AW, May RE, Mitch WE. Comparison of peptide and no peptide receptor mediated responses in the rat fail artery. J Cardiovasc Pharmacol 1992;20:282-9.
10. Leclerc F, Walter-Nicolet E, Leteurtre S, Noizet O, Sadik A, Cremer R. Admission plasma vasopressin levels in children with meningococcal septic shock. Intensive Care Med 2003;29:1339-44.
11. Dunser MW, Mayr AJ, Ulmer H, Ritsch N, Knotzer H, Pajk W, et al. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and post cardiotomy shock: a retrospective analysis. Anesth Analg 2001;93:7-11.
12. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 2001;27:1416-21.
13. Argenziano M, Chen JM, Choudhri AF, Cullinane S, Garfein E, Weinberg AD, et al. Management of vasodilatory stock after cardiac surgery: identification of predisposing factors and use of a novel pressor agents. J Thorac Cardiovasc Surg 1998;116:973-80.
14. Dunser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 2003;107:2313-9.
15. Yunge M, Petros A. Angiotensin for septic shock unresponsive to noradrenaline. Arch Dis Child 2000;82:388-9.